NanoRibo (Shanghai) Biotechnology Co., Ltd.
Company Details
Status: Private
Employees: 1-10
Location:
Shanghai, China
Type:
sample
Technology:
sample
sample
About: NanoRibo, founded in May 2021, is a biopharmaceutical technology company specializing in mRNA-related research and development of innovative vaccines and drugs. Our founding team, with over 20 years of expertise in virology and vaccine research, has played pivotal roles in esteemed research institutions and multinational corporations (MNCs) worldwide with extensive involvement in mRNA research and development, granting us genuine mastery of the technical know-how in the mRNA field.
NanoRibo boasts a solid foundation in pathogenic biology, immunology, molecular biology, and bioinformatics. We are dedicated to fostering original innovation and have created a cutting-edge platform for researching and developing mRNA vaccines and drugs. Our mission at NanoRibo is to pioneer the biopharmaceutical industry, excelling in innovation and thriving in the global market.
We possess proprietary non-coding region sequences, codon optimization algorithms, antigen design and optimization methods based on AI/Deep Learning, circRNA purification processes, LNP lyophilization techniques, and other innovative solutions to industry challenges.
Utilizing the advantages of our mRNA technology platform, we focus on addressing the pressing need for enhancing existing technologies or filling gaps in the market for vaccines and other immunotherapies.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
NanoRibo (Shanghai) Biotechnology Co., Ltd. | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.